Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Patient enrollment completed in phase IIa trial of Onyvax-P

April 17, 2003

AG-858/Gleevec combination therapy subject of new phase II trial in CML

April 15, 2003

Pharmexa seeks approval in Europe for phase II HER-2 DNA AutoVac trial

April 10, 2003

HYB-2055 enters the clinic

April 7, 2003

New patent broadens protection for Virulizin

April 7, 2003

Oxford BioMedica cleared to begin phase II trial of TroVax in colorectal cancer

April 3, 2003

Initiation of first of two expanded phase II trials of GVAX lung cancer vaccine

April 3, 2003

Pharmexa applies to begin phase I trial of HER-2 Protein AutoVac product

April 2, 2003

MediGene discontinues development of CVLP tumor vaccine

March 28, 2003

Protein Design Labs licenses SMART M195 antibody to Actinium

March 20, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...